Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018
January 19 2018 - 4:23PM
Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and
life science component company, expects to release its first
quarter fiscal 2018 operating results before the NASDAQ market
opens on Thursday, January 25, 2018. The release will be available
shortly thereafter on Meridian’s website at
www.meridianbioscience.com.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops,
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, rare reagents, specialty biologicals and
components. Utilizing a variety of methods, our diagnostic tests
provide accuracy, simplicity and speed in the early diagnosis and
treatment of common medical conditions, such as infections and lead
poisoning. Meridian’s diagnostic products are used outside of the
human body and require little or no special equipment. The
Company's diagnostic products are designed to enhance patient
well-being while reducing the total outcome costs of health care.
Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, and blood lead
level testing. In addition, Meridian is a supplier of rare
reagents, specialty biologicals and components used by
organizations in the life science and agri-bio industries engaged
in research. Many companies also utilize Meridian’s products as
components in the manufacture of diagnostics. The Company markets
its products and technologies to hospitals, reference laboratories,
research centers, diagnostics manufacturers and agri-bio companies
in more than 70 countries around the world. The Company’s shares
are traded on the NASDAQ Global Select Market, symbol VIVO.
Meridian's website address is www.meridianbioscience.com.
Contact:Jack KennyChief Executive
OfficerMeridian Bioscience, Inc. Phone:
513.271.3700Email: mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Sep 2023 to Sep 2024